Escudero-Ortiz, V.;                     DomÃnguez-Leñero, V.;                     Catalán-Latorre, A.;                     Rebollo-Liceaga, J.;                     Sureda, M.    
        Relevance of Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in Routine Clinical Practice: A Pilot Study. Pharmaceutics 2022, 14, 1216.
    https://doi.org/10.3390/pharmaceutics14061216
    AMA Style
    
                                Escudero-Ortiz V,                                 DomÃnguez-Leñero V,                                 Catalán-Latorre A,                                 Rebollo-Liceaga J,                                 Sureda M.        
                Relevance of Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in Routine Clinical Practice: A Pilot Study. Pharmaceutics. 2022; 14(6):1216.
        https://doi.org/10.3390/pharmaceutics14061216
    
    Chicago/Turabian Style
    
                                Escudero-Ortiz, Vanesa,                                 Vanessa DomÃnguez-Leñero,                                 Ana Catalán-Latorre,                                 Joseba Rebollo-Liceaga,                                 and Manuel Sureda.        
                2022. "Relevance of Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in Routine Clinical Practice: A Pilot Study" Pharmaceutics 14, no. 6: 1216.
        https://doi.org/10.3390/pharmaceutics14061216
    
    APA Style
    
                                Escudero-Ortiz, V.,                                 DomÃnguez-Leñero, V.,                                 Catalán-Latorre, A.,                                 Rebollo-Liceaga, J.,                                 & Sureda, M.        
        
        (2022). Relevance of Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in Routine Clinical Practice: A Pilot Study. Pharmaceutics, 14(6), 1216.
        https://doi.org/10.3390/pharmaceutics14061216